|
|
| | N,N-didesmethyl AH 7921 Basic information |
| Product Name: | N,N-didesmethyl AH 7921 | | Synonyms: | N,N-didesmethyl AH 7921;Benzamide, N-[(1-aminocyclohexyl)methyl]-3,4-dichloro-;N-[(1-aminocyclohexyl)methyl]-3,4-dichloro-benzamide | | CAS: | 1580956-92-8 | | MF: | C14H18Cl2N2O | | MW: | 301.21 | | EINECS: | | | Product Categories: | | | Mol File: | 1580956-92-8.mol |  |
| | N,N-didesmethyl AH 7921 Chemical Properties |
| Boiling point | 430.7±35.0 °C(Predicted) | | density | 1.243±0.06 g/cm3(Predicted) | | solubility | DMF: 10 mg/ml; DMSO: 3 mg/ml; Ethanol: 11 mg/ml; Ethanol:PBS(pH 7.2) (1:1): 0.5 mg/ml | | form | A crystalline solid | | pka | 13.57±0.46(Predicted) |
| | N,N-didesmethyl AH 7921 Usage And Synthesis |
| Description | N,N-didesmethyl AH 7921 is an analytical reference standard that is structurally categorized as an opioid metabolite. It is a predominant metabolite of AH 7921 incubated with human liver microsomes that is also abundant in hydrolyzed urine case samples.1 The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic applications. | | Uses | N,N-didesmethyl AH 7921 is structurally categorized as an opioid metabolite and is a metabolite of AH 7921[1]. | | References | 1. Wohlfarth, A., Scheidweiler, K.B., Pang, S., et al. Metabolic characterization of AH-7921, a synthetic opioid designer drug: In vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmation Drug Test Anal. 8(8),779-791(2016). |
| | N,N-didesmethyl AH 7921 Preparation Products And Raw materials |
|